Results 181 to 190 of about 588,707 (355)
4‐HBA upregulates NKIRAS2 levels, inhibiting the activation of the NF‐κB pathway and subsequently reducing the levels of neuroinflammatory markers. This modulation helps restore normal mood and behavior in hyperlipidemic conditions, providing a potential therapeutic strategy for managing hyperlipidemia‐associated depression.
Ying Zhang +7 more
wiley +1 more source
Targeting Pathways Implicated in Cholesterol Metabolism for Novel Cancer Therapy. [PDF]
Zhou Y +15 more
europepmc +1 more source
High‐content Stimulated Raman Scattering (SRS) Imaging reveals that ovarian cancer cells surviving Chimeric Antigen Receptor (CAR) ‐T cell challenge exhibit increased cholesterol esterification. Pharmacological inhibition of this pathway with Avasimibe significantly enhances CAR‐T induced killing of ovarian cancer cells by reducing cancer cell ...
Chinmayee V. Prabhu Dessai +8 more
wiley +1 more source
The emerging role of cholesterol metabolism in gynecologic cancer development and therapy. [PDF]
Liu H +7 more
europepmc +1 more source
CHOLESTEROL METABOLISM IN MAN [PDF]
M D, SIPERSTEIN, A W, MURRAY
openaire +2 more sources
Celastrol upregulates adipocyte‐derived exosomal miR‐5099, suppressing the macrophage c‐Met/NF‐κB axis to mitigate pro‐inflammatory M1 polarization and adipose inflammation. These miR‐5099‐enriched exosomes also act as endocrine signals targeting the liver, muscle, and adipocytes to significantly enhance systemic insulin sensitivity.
Ping Tang +9 more
wiley +1 more source
Single-cell mapping of cholesterol metabolism reveals FDPS as a therapeutic vulnerability in hepatocellular carcinoma. [PDF]
Yang X, Li J, Wang Y, Gao Q, Zhang M.
europepmc +1 more source

